Just diagnosed with Mixed phenotype acute leukemia?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Mixed phenotype acute leukemia, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Mixed phenotype acute leukemia hub →Overview
Mixed phenotype acute leukemia is a rare condition. Also known as MPAL. Tomeko brings together the specialists, research, clinical trials, treatments and community for Mixed phenotype acute leukemia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:530995 · OMIM 601626 · ICD-10 C95.0 · GARD 0017972
Find care for Mixed phenotype acute leukemia
Authoritative references for Mixed phenotype acute leukemia
Research & market landscape for Mixed phenotype acute leukemia
Following Mixed phenotype acute leukemia for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Mixed phenotype acute leukemia — the real-world landscape behind the condition, in one place.
- Latest Mixed phenotype acute leukemia research on PubMed ↗
- Recruiting Mixed phenotype acute leukemia trials on ClinicalTrials.gov ↗
- Explore the Mixed phenotype acute leukemia research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Mixed phenotype acute leukemia and every rare condition. See how Tomeko works with industry →
Common questions
What is Mixed phenotype acute leukemia?
Mixed phenotype acute leukemia is a rare condition. Also known as MPAL. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Mixed phenotype acute leukemia together in one place.
What are the symptoms of Mixed phenotype acute leukemia?
Symptoms of Mixed phenotype acute leukemia vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Mixed phenotype acute leukemia.
How is Mixed phenotype acute leukemia treated?
Treatment for Mixed phenotype acute leukemia depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Mixed phenotype acute leukemia, and review current options with them.
What causes Mixed phenotype acute leukemia — is it genetic?
The cause and inheritance of Mixed phenotype acute leukemia are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Mixed phenotype acute leukemia can explain what it means for you and your family.
I was just diagnosed with Mixed phenotype acute leukemia — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Mixed phenotype acute leukemia, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Mixed phenotype acute leukemia?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Mixed phenotype acute leukemia, filtered to your area.
Are there clinical trials for Mixed phenotype acute leukemia?
Tomeko shows live, recruiting studies for Mixed phenotype acute leukemia from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: